Evidence map›Paper›PMID 35912093›Full record

ReviewFrontiers in cell and developmental biology2022

Cathepsin K

Nanyu Zou, Ran Liu, Changjun Li

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Conditional deletion ofFrontiers in cell and developmental biology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Progress on the mechanism of Polycystin-1 in bone remodeling.Frontiers in cell and developmental biology · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Nanyu ZouDepartment of Endocrinology, Endocrinology Research Center, The Xiangya Hospital of Central South University, Changsha, China.
Ran LiuDepartment of Endocrinology, Endocrinology Research Center, The Xiangya Hospital of Central South University, Changsha, China.
Changjun LiDepartment of Endocrinology, Endocrinology Research Center, The Xiangya Hospital of Central South University, Changsha, China.
Central South University · CNSoil and Fertilizer Institute of Hunan Province · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cathepsin K (Ctsk) is a cysteine protease of the papain superfamily initially identified in differentiated osteoclasts; it plays a critical role in degrading the bone matrix. However, subsequent

Indexed as

animal modelbone metabolic diseasecathepsin KCtsk+ cellsgenetic marker

Identifiers

PMID35912093
PMCPMC9326176
OpenAlexW4285085348

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.